• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Perfusion . Long-term venovenous extracorporeal membrane oxygenation support for acute respiratory distress syndrome after COVID-19

tetano

Editor, Senior Moderator
Perfusion


. 2023 Dec 8:2676591231221470.
doi: 10.1177/02676591231221470. Online ahead of print. Long-term venovenous extracorporeal membrane oxygenation support for acute respiratory distress syndrome after COVID-19

Wei Wang[SUP] 1 [/SUP], Ying Feng[SUP] 2 [/SUP], Zhenzhen Li[SUP] 1 [/SUP], Xin Lin[SUP] 2 [/SUP], Ruixia Song[SUP] 2 [/SUP], Gang Chen[SUP] 2 [/SUP], Ruchao Ma[SUP] 2 [/SUP], Guiqing Ma[SUP] 2 [/SUP]



Affiliations
Abstract

Introduction: Acute respiratory syndrome (ARDS) following coronavirus 2 (SARS-CoV-2) infection is a serious complication often causing irreversible lung injury associated with high mortality. Extracorporeal membrane oxygenation (ECMO) may be initiated in severe cases. We present a case of ARDS following SARS-CoV-2 infection with prolonged duration ECMO (1045 hours, 44 days) without exchanging circuit throughout the whole duration without technical complication.
Case report: A 71-year-old man of acute respiratory failure secondary to SARS-CoV-2 infection was initiated on venovenous ECMO (VV-ECMO). There was no technical complication without exchanging circuit throughout the whole prolonged ECMO duration (1045 hours, 44 days). Despite a great effort to improve his lung mechanics and gas exchange, there was continued clinical and physiological deterioration unfortunately. Following family discussion and with input from the multidisciplinary team (MDT) including palliative care specialists, there was recognition of deterioration despite optimal respiratory support. Shortly thereafter planned withdrawal occurred, and the patient passed away with his family at his bedside.
Discussion: This case study illustrates that it may be considered to use long term ECMO as a bridge to recovery or lung transplantation of ARDS patient after SARS-CoV-2 infection with severe lung injury. Benefits from proper long-term ECMO management,it is possible of sparing to exchange circuit throughout the whole prolonged duration without technical complication.
Conclusion: This case indicates the feasibility of using of a long term VV-ECMO as a bridge to recovery or lung transplantation of ARDS patient after secondary to coronavirus 2 (SARS-CoV-2) infection with severe lung injury without circuit exchange. The optimal duration of VV-ECMO support and optimal diagnostic modalities for critical assessment of native lung recovery or irretrievable severe lung injury still require further investigation.

Keywords: SARS-CoV-2; acute respiratory syndrome; extracorporeal gas exchange; extracorporeal membrane oxygenation; severe lung injury.

 
Back
Top Bottom